Virus de la viruela: la enfermedad más letal podría volver

La Viruela: Un Virus Mortal

The video discusses the characteristics, transmission, symptoms, historical impact, and potential resurgence of the smallpox virus.

Smallpox Virus Characteristics

• Smallpox belongs to the poxvirus group, being one of the largest viruses visible under a regular microscope.

• Smallpox exclusively affects humans and is inert until it encounters a cell for replication.

• Transmission occurs through tiny saliva droplets expelled during coughing or sneezing.

Symptoms and Impact

• Initial symptoms include redness and swelling leading to blisters and pustules.

• Severe cases result in widespread pustules causing immobility and excruciating pain.

• Smallpox mortality rates ranged from 20% to 50%, devastating the immune system.

Resurgence Concerns

The video explores concerns regarding the potential reemergence of smallpox due to synthetic recreation.

Synthetic Recreation

• In 2016, a Canadian scientist synthesized horse smallpox virus DNA fragments.

• Creating new poxviruses is feasible by combining different genes, posing significant risks.

Edward Jenner's Vaccination Discovery

Edward Jenner's groundbreaking work on vaccination against smallpox is highlighted.

Jenner's Vaccination Method

• Edward Jenner observed that milkmaids exposed to cowpox were immune to smallpox.

• In 1796, Jenner inoculated an 8-year-old with cowpox material as a preventive measure against smallpox.

Impact of Vaccination

• The inoculated child remained unaffected when exposed to smallpox virus later on.

• Jenner coined the term "vaccine" from Latin "vacca," signifying his breakthrough in immunization.

Defeat of Smallpox Through Vaccination

The triumph over smallpox through vaccination is emphasized as a victory over nature.

Triumph Over Smallpox

• Thomas Jefferson credited Jenner for eradicating smallpox globally with his vaccine discovery.

The Threat of Smallpox Resurgence

The discussion revolves around the potential threat posed by the resurrection of smallpox, a virus that was eradicated but still exists in two laboratories. There is a debate on whether to preserve or destroy the remaining samples.

Smallpox Eradication and Preservation Debate

• The dilemma arises regarding whether to retain or eliminate the last smallpox samples, even though they are stored in highly secure laboratories.

• Initially, there was consensus to destroy the remaining samples post-research. However, concerns about its weaponization emerged in the 90s.

• After the fall of the Soviet Union, revelations about secret biological weapons experiments in Russia heightened global apprehensions.

• Ken Alibeck disclosed extensive biological warfare activities across various locations in the Soviet Union, emphasizing weapon development and population contagion systems.

Bioterrorism Concerns and Government Response

The narrative delves into bioterrorism threats and governmental actions following alarming disclosures about biological warfare capabilities.

Bioterrorism Revelations and Response

• Detailed accounts reveal 40,000 scientists working on bioweapons with a focus on viruses like smallpox for maximum enemy impact.

• Bill Clinton's attention shifted to bioterrorism after testimonies from defectors like Ken Alibeck raised alarms, leading to a decision not to destroy smallpox stocks for research purposes.

Global Events Impacting Smallpox Stock Retention

Global events such as 9/11 and anthrax attacks influenced decisions regarding retaining smallpox stocks for research and vaccine development.

Global Events Influence Decision Making

• Post 9/11 attacks and anthrax incidents, fear escalated globally prompting a shift towards preserving smallpox stocks due to heightened bioterrorism concerns.

• Temporary retention of smallpox stocks until 2002 was agreed upon by committees amidst rising terrorism fears post-global incidents.

Vaccine Preparedness Amidst Bioterrorism Threat

The urgency to bolster vaccine supplies against potential bioterrorist threats led to rapid production escalation efforts.

Vaccine Production Acceleration

• Inadequate vaccine reserves prompted swift action post-anthrax attacks with significant efforts securing funding for mass vaccine production within 18 months.